Transcript OHP Logo + slogan - One Health Platform

Creating a healthy future
for humans, animals and
their environments.
Our mission
The One Health Platform is a strategic forum of
stakeholders and a One Health reference network that
aims to enhance understanding of and preparedness for
the current and future outbreaks of zoonoses, emerging
infectious diseases in humans and animals, and
antimicrobial resistance, including the ecological and
environmental factors which impact on these diseases.
Structure
Structure
Management Board
 Prof. Ab Osterhaus, Professor of Wildlife
Virology and Virus Discovery, Hannover,
Germany, Germ
 Prof. John McKenzie, Research Associate &
Professor of Tropical Infectious Diseases at
Curtin University, Australia
 Mrs. Chris Vanlangendonck, Semiotics
(daily management and communication)
Structure
Scientific Advisory Board
 Comprises of key scientific
experts, representing the
different One Health disciplines
 Determines the organisation's
policy roadmap
Structure
Patron and Honorary Board member
 Peter Doherty, professor of
Microbiology and Immunology at the
University of Melbourne, Australia
Structure
Scientific Advisory Board Members
Ab Osterhaus, professor of Wildlife Virology and Virus Discovery,
Hannover, Germany
John McKenzie, Research Associate & Professor of Tropical Infectious
Diseases at Curtin University, Australia
David Heymann, Chair of Health Protection Agency, UK
Giuseppe Cornaglia, professor of microbiology at Verona University,
Italy
Martyn Jeggo, Director of the Geelong Centre for Emerging Infectious
Diseases, Australia
Christian Drosten, Director of the Institute of Virology at University of
Bonn Medical Centre, Germany
Lone Simonsen, professor of Global Health at George Washington
University, USA
Peter Daszak, President of the EcoHealth Alliance
George Gao, Deputy Director-General CDC China
Frederick Murphy, University of Texas, USA
Amadou Alpha Sall, Institut Pasteur de Dakar, Senegal
Structure
Scientific Advisory Board Members
Derek Smith, Professor of Infectious Disease Informatics, Cambridge
University, UK
Rita Colwell, Johns Hopkins University Bloomberg School of Public Health,
USA
Linfa Wang, Duke-NUS Graduate Medical School, Singapore
Mark Rweyemamu, Director of the Southern African Centre for Infectious
Diseases and Surveillance (SACIDS)
Edward Holmes, Marie Bashir Institute for Infectious Diseases & Biosecurity,
University of Sydney, Australia
Tom Monath, CO & CSO at BioProtection Systems/NewLink Genetics Corp.,
USA
Nick Juleff, Senior Program Officer Animal Health portfolio, Bill & Melinda
Gates Foundation
Dennis Carroll, Director Global Health Security and Development, USAID
Larry Madoff, Editor ProMED-mail ISID, Professor of Medicine, University of
Massachusetts
Structure
Scientific Advisory Board Members
Structure
Industry Advisory Group
 Assembles One Health industry
partners
 Closely interacts with the
Scientific Advisory Board to
advocate and implement the
organization’s policy roadmap
Structure
International One Health Coalition
 Assembles international
governmental and nongovernmental organizations and
institutions
 Bridges the gap between
evidence and policy
Structure
International One Health Coalition
Structure
Ad hoc collaboration with…
And expansion is ongoing…
Structure
Early Career Researchers Circle
 Aims to have a positive impact on the
careers of promising researchers
through scholarships, awards and
networking
 Coordinator: Leslie Reperant, Artemis
One Health, Utrecht, The Netherlands
The public one health agenda
The public one health agenda
To prepare for future outbreaks of EID,
we need to enhance our
understanding of the drivers for
emerging infections, especially at the
human/animal interface. The One
Health Platform Research Agenda lists
10 priority research areas.
• Strengthening surveillance and
laboratory capacity
• Ensuring uninterrupted access to
essential medicines of assured
quality
• Regulation and promotion of
rational use of medicines
• Enhancing infection prevention
and control
• Fostering research and
development for new medicines
and tools
The World Health Organization’s
policy package to combat
antimicrobial resistance
The Science Policy Interface
bridges the gap between
evidence and health policy.
Experts ‘translate’ the policy
implications of their research
and use high-quality data to
guide discussions, and ultimately - to improve the
health of humans, animals and
the environment through
evidence-based policy.
Our activities
Annual General Assembly Meeting
 Annual gathering of Scientific Advisory Board, Industry
Advisory Board and International One Health Coalition
 Coordinates the implementation of the Public One
Health Agenda
 Determines the organization’s scientific and policy
priorities
Our activities





Programme reflects Public One Health Agenda:
Theme: One Health in underserved communities
Co-organizer: University of Saskatchewan
One Health Fellowship Fund
www.onehealthcongress.com
Our activities

3 november
 Promoting efforts around the
world to bring together all
human, animal, and
environmental health disciplines
Our dissemination tools
Monthly Media Bulletins
www.onehealthplatform.com
One Health Journal
One Health 'newspaper’
Social Media
Industry Advisory Board Membership

Annual fee: €25,000/year

Value Proposition:
 Participation in the Annual General Assembly Meetings
 Contribution to the development of the International One
Health Congress Programme
 Determining the organization’s research and policy priorities in
close interaction with the Scientific Advisory Board and the
International One Health Coalition
 From philanthropy to market/shaping the environment